Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma

Head and Neck

Volumn 26, Issue 5, 2004, Pages 435-441

  Rischin, Danny ^a   Porceddu, Sandro ^a   Peters, Lester ^a   Martin, Jarad ^a   Corry, June ^a   Weih, LeAnn ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Chemoradiation therapy; Induction chemotherapy; Sinonasal undifferentiated carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; AREA UNDER THE CURVE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; OTOTOXICITY; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SINONASAL UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; PROBABILITY; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2342628683     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10396     Document Type: Review

References (19)

1. Frierson HF Jr, Mills SE, Fechner RE, et al. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 1986;10: 771-779.
2. Levine PA, Frierson HF Jr, Stewart FM, et al. Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm. Laryngoscope 1987;97A:905-908.
3. Deutsch BD, Levine PA, Stewart FM, et al. Sinonasal undifferented carcinoma: a ray of hope. Otolaryngol Head Neck Surg 1993;108:697-700.
4. Righi PD, Francis F, Aron BS, Weitzner S, et al. Sinonasal undifferentiated carcinoma: a 10-year experience. Am J Otolaryngol 1996;17:167-171.
5. Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 2002; 26:371-376.
6. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002;15:264-278.
7. Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002;112:1450-1455.
8. Cerilli LA, Holst VA, Brandwein MS, et al. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 2001; 25:156-163.
9. Gallo O, Graziani P, Fini-Storchi O. Undifferentiated carcinoma of the nose and paranasal sinuses. An immunohistochemical and clinical study. Ear Nose Throat J 1993;72:588-595.
10. Miyamoto RC, Gleich LL, Biddinger PW, Gluckman JL. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 2000; 110:1262-1265.
11. Smith SR, Som P, Fahmy A, et al. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope 2000;110: 1617-1622.
12. Jiang GL, Morrison WH, Garden AS, et al. Ethmoid sinus carcinomas: natural history and treatment results. Radiother Oncol 1998;49:21-27.
13. Peters L, Rischin D, Corry J. Evolving concepts in chemoradiotherapy for head and neck cancer. In: Kogelnik HD, PLFS. Proc. 7th International Meeting on Progress in Radio-Oncology. Bologna: Monduzzi Editore; 2002. p 17-23.
14. Rischin D, Peters L. The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: where does the chemotherapy piece fit? J Clin Oncol 2002;20:1968-1970.
15. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy versus radiotherapy alone in stage IV(≥N2, MO) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial. Int J Radiat Oncol Biol Phys 1996;35:463-469.
16. Ma J, Mai HQ, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1350-1357.
17. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
18. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
19. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326:524-530.